Pulmatrix

Pulmatrix is a biotechnology company headquartered in India. Founded in 2000, the company specializes in developing innovative respiratory therapies. Pulmatrix focuses on creating novel medicines utilizing its proprietary iSPERSE® technology. This technology enables the efficient delivery of both respiratory and non-respiratory therapies through the respiratory system. Pulmatrix's commitment to delivering transformative medicines is evident in its dedication to clinical trials and partnerships aimed at bringing its therapies to patients worldwide. Contact Pulmatrix via pulmatrix.com.

Pulmatrix, Inc. is a biopharmaceutical company specializing in the development of innovative inhaled therapies. The company's board of directors includes individuals with extensive experience in the pharmaceutical and biotechnology industries. Pulmatrix, Inc. operates within the healthcare, biotechnology, and pharmaceuticals industries. The company's address is listed as 945 Concord Street, Suite 1217, Framingham MA 01701, and 36 Crosby Drive, Suite 100, Bedford, MA 01730-1447. Contact information includes phone numbers (781) 357-2333 and (888) 355-4440, as well as email addresses [email protected], [email protected], and [email protected]. Pulmatrix, Inc. benefits from over two decades of experience with biotech start-ups. The company also possesses significant expertise in inhaled drug development. The Chairman of the PULMATRiX Board of Directors is Michael J. Higgins, who is also an Entrepreneur-in-residence at Polaris Partners. Anand Varadan serves as the Executive Vice President, Chief Commercial Officer at Chiasma. Rick Batycky is the Chief Executive Officer, Nocion Therapeutics. Chris Cabell is the Senior Vice President, Head of Clinical Development, at Emergent BioSolutions. Todd Bazemore is the Chief Operating Officer, Kala Pharmaceuticals.